Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.
This study is not yet open for participant recruitment.
Study NCT00729976   Information provided by Assaf-Harofeh Medical Center
First Received: August 6, 2008   Last Updated: August 7, 2008   History of Changes

August 6, 2008
August 7, 2008
September 2008
December 2009   (final data collection date for primary outcome measure)
Maximal change in temperature during the 4-hour period after enrollment. [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00729976 on ClinicalTrials.gov Archive Site
Proportion of patients with a drop of at least 1°C and 2°C in mean temperature at 4h. Decrement in fever at each time point, and the area under the temperature (versus time) curve. Proportion of patients with temperature < 38 at 4 hours. [ Time Frame: 4 h ] [ Designated as safety issue: No ]
Same as current
 
Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.
Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.

Fever is one of the most common symptoms in pediatrics and one of the most common reasons for visits in pediatricians' office and pediatric emergency departments. Many parents consider fever to be the most terrifying symptom.

Ibuprofen is an effective and safe treatment for febrile children. Until recently ibuprofen was available only in tablets suspension and as a liquid gel. All these dosage form are administered orally. Rectal suppositories are often essential for treating febrile children who cannot take medications by mouth (e.g vomiting). In the current study we aim to compare the effect on fever of ibuprofen given as suspension with ibuprofen suppositories.

 
Phase IV
Interventional
Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Fever
  • Drug: Ibuprofen suppository
  • Drug: Ibuprofen Suspension
  • Experimental: Ibuprofen Suppository
  • Active Comparator: Ibuprofen suspension
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Not yet recruiting
70
June 2010
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

Age: 3 mo- 4 years

  • Weight 6 - 18 kg
  • Rectal temperature > 38.50

Exclusion Criteria:

  • Treatment with acetaminophen in the last 4 hours
  • Treatment with Ibuprofen in the last 6 hours
  • Unable to take oral or rectal medications
  • Hypersensitivity to ibuprofen
  • Renal failure
  • Liver disease
  • Rectal temperature can't be measured (due to anatomical or medical problem)
  • Informed consent could not be granted
Both
3 Months to 5 Years
No
Contact: Eran Kozer, MD 972 8 9779916 erank@asaf.health.gov.il
Contact: Ehud Rosenbloom, MD 972 8 9779916 ehudroze@gmail.com
Israel
 
NCT00729976
Eran Kozer, Assaf-Harofeh Medical Center
091/08
Assaf-Harofeh Medical Center
 
 
Assaf-Harofeh Medical Center
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP